| #33 |
Jian Tan |
Guardtime Ip Holdings Limited |
1 |
| #33 |
Jingpin Jia |
Bristol-Myers Squibb |
1 |
| #33 |
Zhen-Wei Cai |
Bristol-Myers Squibb |
1 |
| #33 |
Sergey V. Paushkin |
Ptc Therapeutics |
1 |
| #33 |
Jason Farkas |
Vonage Network |
1 |
| #33 |
Srinivas Patibanda |
Educational Testing Service |
1 |
| #33 |
William J. Parsons |
Johnson & Johnson |
1 |
| #33 |
Anuradha Sekher |
GE |
1 |
| #33 |
Nilgun E. Tumer |
— |
1 |
| #33 |
Brian S. Huffman |
Temptime |
1 |
| #33 |
Siva Sivaganesh |
Cellco Partnership |
1 |
| #33 |
Guanghui Zhang |
Johnson & Johnson |
1 |
| #33 |
Steven Corda |
Ses S.A. |
1 |
| #33 |
Zhenwei Cai |
Agios Pharmaceuticals |
1 |
| #33 |
Jin Zhuo |
Ptc Therapeutics |
1 |
| #33 |
Anurag S. Srivastava |
Bristol-Myers Squibb |
1 |
| #33 |
Subir Das |
Telcordia Technologies |
1 |
| #33 |
Govindan Subramanian |
Novo Nordisk A/S |
1 |
| #33 |
Sivagnanalingam Sivaganesh |
Verizon |
1 |
| #33 |
Halou Oumar-Mahamat |
ExxonMobil |
1 |
| #33 |
Mark G. Charest |
Novartis Ag |
1 |
| #33 |
Robert Lewis D'Avanzo, Jr. |
Accenture Global Services Limited |
1 |
| #33 |
Suk Yee Wong |
Somos |
1 |
| #33 |
Ruth R. Wexler |
Bristol-Myers Squibb |
1 |
| #33 |
Richard Yang Zhang |
— |
1 |
| #33 |
Thomas Coradetti |
Bio Tillion |
1 |
| #33 |
Pingyi Zhang |
Development |
1 |
| #33 |
Ximin Gong |
Disney |
1 |
| #33 |
Ping Wen |
Delta Electronics |
1 |
| #33 |
Joseph H. Kang |
Alcatel Lucent |
1 |
| #33 |
Xiaoyan Zhang |
Biomed Valley Discoveries |
1 |
| #33 |
James Mathew |
Micron |
1 |